Cytokinetics | CYTK - Beneficio Bruto En Ventas





Beneficio Bruto En Ventas Cambio Fecha
Acadia Pharmaceuticals USD 279.64M 36.37M 2026-06
Amgen USD 5.87B 1.02B 2026-03
Arca Biopharma 0 0 2025-03
Bayer EUR 6.33B 1.84B 2026-06
Biogen USD 2.12B 307M 2026-06
Bristol-Myers Squibb USD 9.26B 1.19B 2026-06
Capricor Therapeutics 11.13M 8.87M 2024-12
Cytokinetics USD 23.03M 3.84M 2026-06
Eisai JPY 183.24B 29.83B 2026-06
Eli Lilly USD 16.22B 301.7M 2026-03
Exelixis USD 608.03M 17.17M 2026-06
Geron USD 50.14M 3.44M 2026-03
Halozyme Therapeutics USD 297.47M 75.53M 2026-03
Ionis Pharmaceuticals USD 265M 22M 2026-06
Ligand Pharmaceuticals USD 100.41M 51.96M 2026-06
Merck USD 12.09B 1.24B 2026-03
Novartis USD 11.24B 1.18B 2026-06
Pfizer USD -248M 11.29B 2026-06
Regeneron Pharmaceuticals USD 3.71B 778.2M 2026-06
Roche Holding CHF 22.69B 600M 2026-06
Sanofi EUR 8.71B 602M 2026-06